Medix Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	951	-	-	-	-	Upgrade
Depreciation & Amortization	45	-	-	-	-	Upgrade
Other Operating Activities	-376	-	-	-	-	Upgrade
Change in Accounts Receivable	66	-	-	-	-	Upgrade
Change in Accounts Payable	-127	-	-	-	-	Upgrade
Change in Other Net Operating Assets	-60	-	-	-	-	Upgrade
Operating Cash Flow	499	-	-	-	-	Upgrade
Capital Expenditures	-14	-	-	-	-	Upgrade
Sale (Purchase) of Intangibles	-3	-	-	-	-	Upgrade
Other Investing Activities	426	-	-	-	-	Upgrade
Investing Cash Flow	414	-	-	-	-	Upgrade
Long-Term Debt Repaid	-229	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	-229	-	-	-	-	Upgrade
Issuance of Common Stock	368	-	-	-	-	Upgrade
Dividends Paid	-60	-	-	-	-	Upgrade
Other Financing Activities	-3	-	-	-	-	Upgrade
Financing Cash Flow	76	-	-	-	-	Upgrade
Miscellaneous Cash Flow Adjustments	1	-	-	-	-	Upgrade
Net Cash Flow	990	-	-	-	-	Upgrade
Free Cash Flow	485	-	-	-	-	Upgrade
Free Cash Flow Margin	11.66%	-	-	-	-	Upgrade
Free Cash Flow Per Share	62.04	-	-	-	-	Upgrade
Cash Interest Paid	2	-	-	-	-	Upgrade
Cash Income Tax Paid	375	-	-	-	-	Upgrade
Levered Free Cash Flow	433	-	-	-	-	Upgrade
Unlevered Free Cash Flow	434.25	-	-	-	-	Upgrade
Change in Working Capital	-121	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.